<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911031-0134</DOCNO><DOCID>911031-0134.</DOCID><HL>   Technology:   Mylan Labs Unit's Purchase</HL><DATE>10/31/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B8</SO><CO>   MYL</CO><MS>CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)</IN><NS>ACQUISITIONS andamp; MERGERS, TAKEOVERS, BOARD BATTLES (TNM)</NS><RE>NORTH AMERICA (NME)PENNSYLVANIA (PA)TEXAS (TX)UNITED STATES (US)</RE><LP>   PITTSBURGH -- Mylan Laboratories Inc. said its MLI Inc.unit has completed the previously announced acquisition ofDow B. Hickam Inc., a pharmaceutical marketing company basedin Sugar Land, Texas. Hickam now is a subsidiary of Mylan.</LP><TEXT/></DOC>